CMTA

Clementia Pharmaceuticals Inc.
CMTA

Overview Fund Activity
Delisted

CMTA was delisted on the 17th of April, 2019.

Back to rankings

31 hedge funds and large institutions have $352M invested in Clementia Pharmaceuticals Inc. in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+4
Holders Change %
+14.81%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
9
Increased
15
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$43.8M
2
PA
2
Perceptive Advisors
New York
$17.6M
3
NMC
3
NEA Management Company
Maryland
$31.8M
4
PHS
4
PFM Health Sciences
California
$10M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$17.4M

Top Sellers

1
SAM
1
Sectoral Asset Management
Quebec, Canada
$0
2
RSCM
2
Rock Springs Capital Management
Maryland
$3.23M
3
WMSA
3
Weiss Multi-Strategy Advisers
New York
$1.24M
4
LCM
4
Laurion Capital Management
New York
$433K
5
TI
5
Trexquant Investment
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$292K +$292K +24,860 New
Northern Trust
27
Northern Trust
Illinois
$191K +$27.5K +2,335 +17%
OAM
28
Oxford Asset Management
United Kingdom
$154K +$154K +13,057 New
TRCT
29
Tower Research Capital (TRC)
New York
$33K +$27.5K +2,335 +505%
PCM
30
Prelude Capital Management
New York
$18K -$8.47K -721 -32%
FDCDDQ
31
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5.88K -$11.8K -1,000 -67%
SAM
32
Sectoral Asset Management
Quebec, Canada
– -$1.38M -123,405 Closed
TI
33
Trexquant Investment
Connecticut
– -$126K -11,275 Closed
Goldman Sachs
34
Goldman Sachs
New York
– -$122K -10,981 Closed
1832 Asset Management
35
1832 Asset Management
Ontario, Canada
– -$11K -1,000 Closed
1
2